Latest period
$22.6B
YoY change
+44.3%
5Y CAGR
+136.3%
Peak year (FY2025)
$20.6B
Latest annual
$20.6B
Total Debt history chart for Novo Nordisk (NVO) from 2016 to 2025
Latest: $20.6B
Total Debt growth chart for Novo Nordisk (NVO) from 2016 to 2025
Latest: +44.3%
Total Debt history table for Novo Nordisk (NVO) from 2003 to 2025
| FY2025 | $20.6B | +44.3% | +$6.32B | ||
| FY2024 | $14.3B | +256.9% | +$10.3B | ||
| FY2023 | $4B | +7.7% | +$286M | ||
| FY2022 | $3.71B | -8.9% | -$363M | ||
| FY2021 | $4.08B | +1358.3% | +$3.8B | ||
| FY2020 | $279M | +176.6% | +$178M | ||
| FY2019 | $101M | +27.8% | +$22M | ||
| FY2018 | $79.1M | -71.0% | -$194M | ||
| FY2017 | $273M | +742.5% | +$241M | ||
| FY2016 | $32.4M | -79.3% | -$124M | ||
| FY2015 | $156M | +33.6% | +$39.3M | ||
| FY2014 | $117M | +194.4% | +$77.3M | ||
| FY2013 | $39.7M | -55.1% | -$48.7M | ||
| FY2012 | $88.4M | -40.5% | -$60.3M | ||
| FY2011 | $149M | -62.8% | -$251M | ||
| FY2010 | $399M | +49.5% | +$132M | ||
| FY2009 | $267M | -38.7% | -$169M | ||
| FY2008 | $436M | +63.0% | +$168M | ||
| FY2007 | $267M | -0.2% | -$669K | ||
| FY2006 | $268M | -37.3% | -$159M | ||
| FY2005 | $427M | +37.3% | +$116M | ||
| FY2004 | $311M | +6.3% | +$18.4M | ||
| FY2003 | $293M | — | — | ||
| FY2002 | — | — | — | ||
| FY2001 | — | — | — | ||
| FY2000 | — | — | — | ||
| FY1999 | — | — | — | ||
| FY1998 | — | — | — | ||
| FY1997 | — | — | — | ||
| FY1996 | — | — | — | ||
| FY1995 | — | — | — | ||
| FY1994 | — | — | — | ||
| FY1993 | — | — | — | ||
| FY1992 | — | — | — | ||
| FY1991 | — | — | — | ||
| FY1990 | — | — | — | ||
| FY1989 | — | — | — | ||
| FY1988 | — | — | — | ||
| FY1987 | — | — | — | ||
| FY1986 | — | — | — | ||
| FY1985 | — | — | — |
- FY2025$20.6B+44.3%
- FY2024$14.3B+256.9%
- FY2023$4B+7.7%
- FY2022$3.71B-8.9%
- FY2021$4.08B+1358.3%
- FY2020$279M+176.6%
- FY2019$101M+27.8%
- FY2018$79.1M-71.0%
- FY2017$273M+742.5%
- FY2016$32.4M-79.3%
- FY2015$156M+33.6%
- FY2014$117M+194.4%
- FY2013$39.7M-55.1%
- FY2012$88.4M-40.5%
- FY2011$149M-62.8%
- FY2010$399M+49.5%
- FY2009$267M-38.7%
- FY2008$436M+63.0%
- FY2007$267M-0.2%
- FY2006$268M-37.3%
- FY2005$427M+37.3%
- FY2004$311M+6.3%
- FY2003$293M—
- FY2002——
- FY2001——
- FY2000——
- FY1999——
- FY1998——
- FY1997——
- FY1996——
- FY1995——
- FY1994——
- FY1993——
- FY1992——
- FY1991——
- FY1990——
- FY1989——
- FY1988——
- FY1987——
- FY1986——
- FY1985——
Total Debt values are taken from Novo Nordisk's reported balance sheets (interim 6-K and annual 20-F filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts converted to USD using IAS 21 average exchange rates (P&L / cash flow) or closing rates (balance sheet). Originally filed in DKK.
About Total Debt at Novo Nordisk (NVO)
According to Novo Nordisk's latest reported financial statements, the company's latest reported total debt is $22.6B. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — compare with cash on hand for net leverage, and total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual total debt for Novo Nordisk (NVO) came in at 131B DKK – grew 27.4% year-over-year.
Novo Nordisk total debt compound annual growth for the 2020–2025 (5 years) window is +138.4%, with mixed annual results across the window.
The highest annual total debt of 131B DKK was reported in 2025. The lowest in the available history was 215M DKK in 2013.
Novo Nordisk Total Debt by Year
Novo Nordisk Total Debt 2025: $20.6B
In 2025, Novo Nordisk reported total debt of 131B DKK ($20.6B), grew 27.4% from 2024. This figure represents the highest annual value in the available history.
Novo Nordisk Total Debt 2024: $14.3B
Novo Nordisk total debt in 2024 was 103B DKK ($14.3B), surged 280.6% from 2023.
Novo Nordisk Total Debt 2023: $4B
2023's total debt for Novo Nordisk came in at 27B DKK ($4B), edged up 4.7% from 2022.
Novo Nordisk Total Debt 2022: $3.71B
Novo Nordisk posted total debt of 25.8B DKK ($3.71B) in 2022, edged down 3.2% below 2021.
Novo Nordisk Total Debt 2021: $4.08B
Novo Nordisk total debt in 2021 was 26.6B DKK ($4.08B).
See more financial history for Novo Nordisk (NVO).
Sector peers by Total Debt
Healthcare peers of Novo Nordisk (NVO), ranked by their latest total debt
| $78.4B | |
| $69.1B | |
| $54.6B | |
| $50.5B | |
| $47.9B | |
| $42.5B | |
| $40.9B | |
| $15.1B |
- $78.4B
- $69.1B
- $54.6B
- $50.5B
- $47.9B
- $42.5B
Frequently asked questions
Novo Nordisk (NVO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks0.23% TTM
- Dividend Profile3.49% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History5 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.